REVB · Revelation Biosciences Inc
United States · RS rating 97 · As of 2026-11-03
| Price | 4.43 USD |
|---|---|
| 1-day change | +9.4% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 99 / 98 / 42 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 38 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +76.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.7% |
| Market cap (USD) | $4.3M |